Use the keywords feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#1
RANDOMIZED CONTROLLED TRIAL
Andrew Thamboo, Jamil Manji, András Szeitz, Rachelle Dar Santos, Iain Hathorn, Eng Cern Gan, Saad Alsaleh, Amin R Javer
BACKGROUND: Budesonide is a potent corticosteroid commonly prescribed for management of inflammation in chronic rhinosinusitis (CRS). The standard for prescribing budesonide is via impregnated nasal saline irrigation (INSI), although recently the mucosal atomization device (MAD) has emerged as a theoretically superior method of distributing medication into the sinuses. The MAD atomizes medication into small droplets and this is thought to enhance absorption and improve bioavailability...
May 2014: International Forum of Allergy & Rhinology
1
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
